• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Aurora Begins Supplying Germany's Medical Marijuana Market

September 19, 2017

 

Aurora Cannabis Inc. (TSX:ACB) (OTCQX:ACBFF) (FRA:21P) has just announced their receipt of the necessary permits to ship dried medical marijuana from Canada to Germany.  This access to the German medical marijuana market is made possible through Aurora's wholly-owned subsidary, Pedanios GmbH.

 

Related: Aurora Passes First Stage of German Producer Application Process

 

Aurora's new Export Permit from Health Canada, combined with their provisional import status from the German government, gives the licensed producer the ability to reach the blossoming German medicinal cannabis market.  

 

Related: Angela Merkel on Cannabis Legalization in Germany

 

On September 18th, Aurora completed their first shipment of dried cannabis totaling 50 kg. The dried cannabis flower was sent from their Mountain View County, Alberta facility to their German subsidiary, marking the first of many shipments, as Aurora has secured additional permits, and scheduled regular ongoing shipments to Pedanios.

 

Related: Cronos Enters Supply Agreement with German Cannabis Importer

 

Pedanios will distribute the cannabis to over 1,500 pharmacies all over Germany and its 80+ million residents.  At the time of writing this, Germany is the largest federally legal medicinal marijuana market on the planet.  This massive market is under supplied and currently going through a shortage of medical cannabis for patients.  Aurora is planning on using its subsidiary Pedanios to position themselves as the largest producer and supplier of medical marijuana to Gemany, and several other markets in the European Union.

 

Related: Naturally Splendid to Distribute Hemp Products in Germany

 

Neil Belot, Aurora's Chief Global Business Development Officer was quoted saying, "This represents a huge milestone for Aurora and Pedanios, and a critical step in our aggressive international expansion strategy."  Belot feels that, " team has done an outstanding job accelerating our entry into Europe. This is the first step in unlocking future potential markets in the EU of several hundred million people, and strongly validates Aurora's acquisition of Pedanios as one of the most significant strategic transactions to date in the cannabis industry."

 

Related: Maricann Raises >$42 MM for German Expansion

 

CEO of Aurora, Terry Booth was proud of the shipment made by his company, saying, "With the receipt of our first international export/import permits and our first shipment to Germany complete, Aurora has further strengthened its position as one of the dominant operators in the global cannabis sector. Germany has more than twice Canada's population, with a rapidly-growing medical cannabis market that can currently be serviced by only four international producers – three of which have distributed product through Pedanios. Moreover, Pedanios provides a well-established gateway to the wider EU market, which continues to grow as additional countries proceed in improving patient access through the establishment of their own national medical cannabis systems. We will continue to diversify our operations, bring the Aurora Standard to new markets, and enjoy first mover advantages as we aim to set the cannabis industry standard across Europe and beyond." 

 

Related: Aurora to Acquire German Cannabis Company

 

Be sure to subscribe to one or more of our free e-mail newsletters so you never miss an important marijuana stock update. Also, don't forget to connect with The Daily Marijuana Observer on social media via Facebook, Twitter, StockTwits, and Instagram.

 

D/M/O

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.